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Introduction {#sec1}
============

Contrary to other processes that are mainly restricted to embryonic development, the differentiation of hematopoietic stem cells (HSCs) into the different blood lineages occurs along the life of the individual. For correct hematopoiesis, HSCs must maintain a fine balance between quiescence and proliferation, and between self-renewal and differentiation. The relevance of HSCs in regenerative medicine is remarkable ([@bib24]), and the possibility of expanding HSCs in vitro, preserving their multipotency, would be a milestone in this regard. Therefore, understanding the orchestration of the multiple intercellular and intracellular signaling events that control HSCs quiescence and self-renewal in vivo should help to attain this goal.

Adult hematopoiesis occurs in the bone marrow (BM), and the importance of this niche in the regulation of HSCs was proposed many years ago ([@bib46]). The BM niche is a complex system formed by different cellular types that support HSCs ([@bib51]). It is increasingly clear that the BM is not homogenous and that different kinds of niche can be found: osteoblastic, vascular, and perivascular. The influence of different types of environments could determine the fate of HSCs, depending on the body's requirements ([@bib14]). At the endosteal niche, HSCs establish direct contact with osteoblasts ([@bib32]). This interaction seems to be important to maintain HSC quiescence ([@bib56], [@bib7]). Moreover, osteoblasts produce soluble factors such as thrombopoietin (TPO) ([@bib55]) or osteopontin (OPN) ([@bib33]), both of which contribute to the maintenance of HSC quiescence.

BM sinusoidal endothelial cells (BMSECs) define the vascular niche ([@bib32]), and different authors have suggested that these cells contribute to regulating the balance between the self-renewal and differentiation of HSCs ([@bib39], [@bib3], [@bib15]).

Within the perivascular niche, two different types of cell seem to display niche functions: CXC chemokine ligand 12 (CXCL-12)-abundant reticular cells (CAR cells) and Nestin^+^ mesenchymal stem cells. CAR cells secrete stem cell factor (SCF) and CXCL12, also known as SDF-1 (stromal cell-derived factor-1) ([@bib39], [@bib3], [@bib15]). Nestin^+^ cells express high levels of genes involved in the regulation of HSCs, and acute depletion of these cells impairs HSC homing after irradiation ([@bib22]).

In order to understand how hematopoiesis is regulated, it is necessary not only to understand the different signals emanating from the niche ([@bib1]), but also to comprehend the integration of these signals by HSCs.

Canonical Wnt signaling has been related to the regulation of HSCs homeostasis ([@bib38]), and it has been reported that a switch toward a non-canonical Wnt signaling causes stem-cell aging ([@bib10]). β-catenin is the nuclear effector of canonical Wnt signaling, and it also behaves as a cell adhesion molecule owing to its interaction with cadherins ([@bib52]). Although it has been shown that Wnt/β-catenin is required for hematopoiesis in *Xenopus* ([@bib50]), the role of β-catenin in mammalian hematopoiesis remains highly controversial ([@bib20]).

We have recently shown that the protein tyrosine phosphatase PTPN13 regulates β-catenin stability and function during in vitro megakaryopoiesis ([@bib43]). Our results also show that PTN13 is stabilized upon Wnt signaling activation, suggesting that PTPN13 is another important player in the context of canonical Wnt signaling ([@bib43]). The deficiency of PTPN13 in mice increases the in vitro differentiation of CD4^+^ T cells toward Th1 and Th2 ([@bib31]), which together with our results ([@bib43]) suggests that PTPN13 may be an important regulator during hematopoiesis.

In the present work, we studied how the downregulation of PTPN13 or β-catenin affects in vivo hematopoiesis. We observed that reduced levels of PTPN13 or β-catenin increase the frequency of ST-HSCs and LT-HSCs, reduce cell cycling, and increase quiescence. Reduced levels of these two proteins are associated with an increased expression of several genes coding for cell adhesion molecules (CAMs), explaining the increased adhesiveness. Moreover, our data show that PTPN13 and β-catenin levels are modulated by mesenchymal cell conditioned medium and different cytokines involved in the control of HSCs, such as Wnt, TPO, CXCL-12, or SCF. Accordingly, we suggest that the regulation of PTPN13 and β-catenin levels in HSCs in response to extracellular signaling is of paramount importance in the regulation of HSC adhesion, cell cycling, and quiescence.

Results {#sec2}
=======

Silencing of PTPN13 and β-Catenin in Murine Hematopoietic Progenitor Cells {#sec2.1}
--------------------------------------------------------------------------

Here, we analyzed the effect of downregulating PTPN13 and β-catenin in mouse hematopoietic stem and progenitor cells (HSPCs) during in vivo hematopoiesis. We have previously shown that PTPN13 and β-catenin interact and colocalize in megakaryocytic cells ([@bib43]). In mouse BM progenitor cells (Lin^--^ cells), we found a strong colocalization of the signals of both proteins ([Figure 1](#fig1){ref-type="fig"}A; [Figure S1](#mmc1){ref-type="supplementary-material"}A). Small hairpin RNAs (shRNAs) against β-catenin or PTPN13 were introduced into mice Lin^--^ cells by lentiviral infection, and an shRNA against firefly luciferase was used as a control ([@bib43]). Cells bearing the different shRNAs were identified by GFP expression. During in vitro culture, no differences were found in the percentage of total GFP^+^ cells ([Figure 1](#fig1){ref-type="fig"}B), GFP^+^ Lin^--^ cells, or GFP^+^ LSK cells ([Figure 1](#fig1){ref-type="fig"}C; [Figure S1](#mmc1){ref-type="supplementary-material"}C) between PTPN13 and β-catenin shRNAs and control cells. The cells were subsequently transplanted into lethally irradiated mice, and in vivo hematopoiesis was followed over 8 weeks after transplantation ([Figure S1](#mmc1){ref-type="supplementary-material"}B). PTPN13 and β-catenin silencing in the mice was checked by quantitative qRT-PCR ([Figure 1](#fig1){ref-type="fig"}D) and by immunoblotting ([Figure 1](#fig1){ref-type="fig"}E) in GFP^+^ purified cells ([Figure S1](#mmc1){ref-type="supplementary-material"}D). When we analyzed the percentage of GFP^+^ cells in the transplanted animals, no differences were found in peripheral blood (PB), thymus, or spleen ([Figure 1](#fig1){ref-type="fig"}F). However, in the BM the percentages of GFP^+^ and GFP^+^ Lin^--^ cells were significantly reduced upon β-catenin and PTPN13 silencing ([Figure 1](#fig1){ref-type="fig"}F), suggesting that hematopoietic progenitor cells might be affected by PTPN13 and β-catenin downregulation.

PTPN13 and β-Catenin Silencing Increases the Number of HSCs {#sec2.2}
-----------------------------------------------------------

Hematopoietic stem cells (HSCs) are defined by their capacity to sustain the differentiation of all blood lineages ([@bib34]). In mice, it is possible to distinguish different HSC subpopulations on the basis of their surface markers: long-term HSCs (LT-HSCs), which would display an unlimited capacity for self-renewal; short-term HSCs (ST-HSCs), with a limited self-renewal capacity; and multipotent lympho-myeloid progenitors (LMPPs), which would not self-renew ([@bib34], [@bib26], [@bib27]).

Lin^--^ cells were purified from the BM of transplanted mice, GFP^+^ cells were gated, and different subpopulations of HSCs and progenitor cells were identified. Intriguingly, the frequency of LSKs ([Figure 2](#fig2){ref-type="fig"}A), LT-HSC, and ST-HSC ([Figure 2](#fig2){ref-type="fig"}B) subpopulations increased upon PTPN13 or β-catenin downregulation. When we analyzed more committed progenitors, no significant differences were found in LMPPs ([Figure 2](#fig2){ref-type="fig"}B), or granulocyte-monocyte progenitors (GMP) ([Figure 2](#fig2){ref-type="fig"}C). However, a significant decrease in common lymphoid progenitors (CLP), common myeloid progenitors (CMP), and megakaryocyte-erythrocyte progenitors (MEPs) was detected ([Figure 2](#fig2){ref-type="fig"}C). Thus, lower levels of PTPN13 or β-catenin led to a reduction in the total number of engrafted cells, and to a specific enrichment of the most immature populations (LSKs, LT-HSCs, and ST-HSCs).

Downregulation of PTPN13 or β-Catenin Increases Megakaryopoiesis and Lymphopoiesis {#sec2.3}
----------------------------------------------------------------------------------

In agreement with our recently published in vitro data ([@bib43]), the silencing of PTPN13 and β-catenin increased the number of megakaryocytes in vivo ([Figure 2](#fig2){ref-type="fig"}D), which indeed suggests the involvement of these two proteins in megakarypoiesis. Erythroid cells were not modified in the BM or in PB, although their numbers were significantly reduced in spleen ([Figure S2](#mmc1){ref-type="supplementary-material"}A). The percentage of granulocytes was reduced in peripheral blood (PB) and spleen, although no differences were found in bone marrow (BM) when β-catenin or PTPN13 were downregulated. No statistically significant differences were found in macrophages ([Figure S2](#mmc1){ref-type="supplementary-material"}B).

Several reports suggest the involvement of β-catenin ([@bib28], [@bib53]) and PTPN13 ([@bib31]) in T cell differentiation. Our data pointed to a significant decrease in CLPs when PTPN13 or β-catenin was downregulated ([Figure 2](#fig2){ref-type="fig"}C), while the number of CD3^+^ T cells was significantly upregulated in the thymus and PB ([Figure 2](#fig2){ref-type="fig"}E; [Figure S3](#mmc1){ref-type="supplementary-material"}A). In the thymus, we observed a significant increase in CD4 (CD4^+^ CD8^--^) and CD8 (CD4^--^ CD8^+^) single-positive cells ([Figure 2](#fig2){ref-type="fig"}F; [Figure S3](#mmc1){ref-type="supplementary-material"}B), which is consistent with the reduction in the DP and DN4 stages of differentiation ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Regarding the differentiation of B cells, we observed an upregulation in spleen when PTPN13 or β-catenin was downregulated, although no significant differences were found in PB or BM ([Figure S3](#mmc1){ref-type="supplementary-material"}D). No differences were found in B cell maturation ([Figure S3](#mmc1){ref-type="supplementary-material"}E).

In light of the above, our results support the notion of the involvement of PTPN13 and β-catenin in lymphopoiesis, especially in T cell maturation, in agreement with previous reports ([@bib31], [@bib28]).

PTPN13 and β-Catenin Regulate HSC Proliferation and Quiescence {#sec2.4}
--------------------------------------------------------------

The reduced number of GFP^+^ cells within the Lin^--^ fraction when β-catenin or PTPN13 were downregulated could be explained in terms of a lower proliferation rate. To test this possibility, the proportion of Lin^--^ cells in G~0~/G~1~ was analyzed. Our results revealed a mild but significant increase in cells in G~0~/G~1~ phase when β-catenin or PTPN13 were downregulated ([Figure 3](#fig3){ref-type="fig"}A), suggesting an increase in the frequency of non-proliferating cells. To test this further, we studied the percentage of positive cells for the proliferation marker Ki67; the number of proliferating cells was significantly reduced in Lin^--^ cells and in all the subpopulations of HSCs (LSKs, LMPPs, ST-HSCs, and LT-HSCs) upon PTPN13 or β-catenin silencing ([Figure 3](#fig3){ref-type="fig"}B). Cell-cycle activity must be strictly regulated in HSCs, and the balance between proliferation and quiescence is important to ensure hematopoiesis ([@bib35]). The lower number of proliferating cells suggested that PTPN13 or β-catenin silencing might increase quiescence within the HSC compartment. To test this, we analyzed the proportion of quiescent cells by pyronin Y staining experiments ([@bib44]). Our results showed that PTPN13 or β-catenin downregulation increased the proportion of quiescent cells within the LT-HSC and ST-HSC subpopulations ([Figure 3](#fig3){ref-type="fig"}C). Thus, our results suggested that PTPN13 and β-catenin would be involved in controlling the balance between the proliferation and quiescence of HSCs.

PTPN13 and β-Catenin Regulate HSC Attachment to the Bone Marrow Niche {#sec2.5}
---------------------------------------------------------------------

The balance between quiescence and proliferation is determined by intrinsic and extrinsic factors ([@bib17]), the anchorage of HSCs to the BM ([@bib48]) being especially important since it can contribute to the maintenance of LT-HSC quiescence ([@bib55]). We therefore wondered whether the capacity for attachment to the BM niche was affected by PTPN13 or β-catenin levels. BM cells were obtained by bone flushing. Subsequently, the bones were subjected to digestion with collagenase/dispase to release the cells that were strongly attached to the bone. The percentage of Lin^--^ and LSKs within the GFP^+^ gated cells were analyzed in both fractions. The frequency of GFP^+^ Lin^--^ and GFP^+^ LSKs adhered strongly to the bone was greater in the mice in which PTPN13 or β-catenin had been downregulated ([Figure 4](#fig4){ref-type="fig"}A). In control mice, the percentages of LSK cells in both fractions were very similar, but upon PTPN13 or β-catenin downregulation an increase of 1.7- and 2.35-fold occurred, respectively, in the percentage of LSKs strongly attached to the bone when compared to the BM flushed fraction. Histological analysis failed to reveal any obvious differences in the localization at the BM between cells downregulated for PTPN13 or β-catenin in comparison with control cells ([Figure S4](#mmc1){ref-type="supplementary-material"}).

These results suggested that the levels PTPN13 and β-catenin might regulate cell adhesiveness. To test this further, PTPN13 or β-catenin was silenced in HEL cells ([Figures 4](#fig4){ref-type="fig"}B and 4C). The capacity of adhesion to collagen- and fibronectin-coated plates was increased following the silencing of either protein ([Figure 4](#fig4){ref-type="fig"}D). The expression of ten different CAMs was analyzed by qRT-PCR. The expression of several of these genes (*ITGA4*, *CDH1*, *CDH12*, *NCAM2*, and *RELN*) was upregulated upon PTPN13 or β-catenin downregulation ([Figure 4](#fig4){ref-type="fig"}E), which could account for the higher adhesiveness of these cells. This change in expression could be explained whether these genes were β-catenin transcriptional targets. To test this hypothesis, the activity of the *CDH1* gene promoter was analyzed ([Figure 4](#fig4){ref-type="fig"}F). β-catenin overexpression reduced *CDH1* promoter activity, supporting the notion that β-catenin may control the transcription of the CAMs-coding genes referred above.

Regulation of β-Catenin and PTPN13 Levels by Cellular Signaling {#sec2.6}
---------------------------------------------------------------

β-catenin levels are strictly regulated by extracellular signaling, and PTPN13 is involved in this regulation, preventing β-catenin degradation ([@bib43]). We therefore wondered whether the levels of these two proteins could be regulated by signals emanating from the BM niche. To test this idea, we first used a conditioned medium derived from immortalized bone marrow mesenchymal stroma cells (hMSC-TERTs) ([@bib23]). This conditioned medium induced a striking downregulation of PTPN13 and β-catenin in HEL cells ([Figure 5](#fig5){ref-type="fig"}A). With this treatment, the cells became adherent ([Figure S5](#mmc1){ref-type="supplementary-material"}), which could be explained in terms of the observed altered expression of CAMs ([Figure 5](#fig5){ref-type="fig"}B). These results suggested that PTPN13 and β-catenin levels could be regulated by signals emanating from the niche, which in the long run would regulate cell adhesion capacity through control of CAMs expression.

To test this further, we next investigated the effect of several cytokines that have been implicated previously in the regulation of HSCs such as Wnt ([@bib38], [@bib10]), TPO ([@bib37], [@bib55], [@bib41]), CXCL-12 ([@bib49]), and SCF ([@bib13]). Wnt, TPO, and CXCL12 increased PTPN13 and β-catenin levels, while SCF decreased their levels ([Figures 5](#fig5){ref-type="fig"}C and 5D). In sum, PTPN13 and β-catenin levels are modulated by different cytokines involved in the regulation of HSCs. Moreover, we observed that some of the CAMs that were upregulated by PTPN13 or β-catenin silencing were downregulated by Wnt, TPO, or CXCL12 signaling (*ITGA4*, *NCAM2*, or *CDH1*), while SCF signaling exerted the same effect as PTPN13 or β-catenin silencing on the expression of *ITGAL* and *NCAM2* ([Figure 5](#fig5){ref-type="fig"}E).

β-Catenin and PTPN13 Downregulation Increases the Adhesiveness of Hematopoietic Progenitor Cells {#sec2.7}
------------------------------------------------------------------------------------------------

The increased adhesion of HSPCs to the bone in vivo ([Figure 4](#fig4){ref-type="fig"}A) could be explained by an increased adhesiveness of these cells upon PTPN13 and β-catenin downregulation, as we observed for HEL cells ([Figure 4](#fig4){ref-type="fig"}D; [Figure S4](#mmc1){ref-type="supplementary-material"}). To test this further, we analyzed the adhesion capacity of BM mouse progenitor cells in vitro. Two different sources of HSPCs obtained from the transplanted animals were used: the Lin^--^ fraction ([Figure 6](#fig6){ref-type="fig"}A), purified after the BM, and the hematopoietic cells that were more strongly attached to the bone, obtained after digestion with collagenase and dispase ([Figure 6](#fig6){ref-type="fig"}B). We observed increased adhesion to collagen with both sources of cells upon downregulation of PTPN13 or β-catenin. Similar results were found for adhesion to fibronectin. We then analyzed the capacity for adhesion to mouse mesenchymal stroma cells (mMSCs), and in these we also found that the ability HSPCs to adhere to these niche cells was also enhanced by PTPN13 or β-catenin downregulation ([Figures 6](#fig6){ref-type="fig"}A and 6B).

Given that our results suggest that PTPN13 and β-catenin levels might be regulated by niche signals, we considered that it was worth analyzing whether the adhesiveness of HSPCs might be regulated by niche signals. In fact, the adhesion of Lin^--^ cells to collagen and fibronectin was significantly enhanced by treatment with mesenchymal cell-conditioned medium ([Figure 6](#fig6){ref-type="fig"}C). Moreover, we observed a significant decrease in PTPN13 mRNA ([Figure 6](#fig6){ref-type="fig"}D). Although there was no a clear reduction in β-catenin mRNA levels, it is likely that the downregulation of PTPN13 would cause a decrease in β-catenin protein levels, as we have shown previously ([@bib43]). Finally, we observed an upregulation of several CAMs (*Itgal*, *Ncam2*, and *Cdh1*) in the hematopoietic progenitors treated with mesenchymal cell-conditioned medium ([Figure 6](#fig6){ref-type="fig"}E), which could account for the increased adhesiveness ([Figure 6](#fig6){ref-type="fig"}C). In sum, these experiments show that, as was the case for HEL cells, the adhesion capacity of hematopoietic progenitors is altered by PTPN13 and β-catenin downregulation, a process that might be regulated by signaling from the BM niche.

Functional Implications of PTPN13 or β-Catenin in the Regulation of Hematopoietic Progenitors by the BM Niche {#sec2.8}
-------------------------------------------------------------------------------------------------------------

Our in vivo analysis revealed that the downregulation of PTPN13 and β-catenin reduced cell cycling and increased the quiescence of HSCs ([Figure 3](#fig3){ref-type="fig"}). We surmised that this might be related to the increased adhesiveness of these cells to the niche. To test this hypothesis, the quiescence and cell cycling of Lin^--^ progenitors were analyzed under in vitro culture conditions and in co-culture with mMSCs. During in vitro culture, no differences were observed between Lin^--^ cells downregulated for PTPN13 or β-catenin and control cells regarding cell cycling ([Figures 7](#fig7){ref-type="fig"}A and 7B), or quiescence ([Figure 7](#fig7){ref-type="fig"}C). However, upon co-culture with mMSCs the cells downregulated for PTPN13 and β-catenin showed a significant decrease in cell cycling and an increase in quiescence in comparison with control cells, as seen from the decrease in Ki67 marker ([Figure 7](#fig7){ref-type="fig"}A) and the reduced incorporation of BrdU ([Figure 7](#fig7){ref-type="fig"}B), and by the increase in PY staining ([Figure 7](#fig7){ref-type="fig"}C), respectively. Strikingly, when the co-culture experiments were performed using transwell devices, no effects were found, suggesting that the above changes regarding cell cycling and quiescence would require direct cell-cell contact between HSPCs and mMSCs.

Discussion {#sec3}
==========

Understanding the mechanisms that govern the balance between self-renewal and differentiation or between cell-cycle progression and quiescence in HSCs is essential. These processes are regulated by the different signals received by HSCs from the BM niche. Accordingly, it is crucial to understand how these inputs are processed by HSC intracellular signaling. In this work, we show that the levels of PTPN13 and β-catenin are important for regulating HSCs quiescence and cell adhesiveness, and our results suggest that the regulation of the levels of these two proteins by different extracellular signaling pathways might be essential for the regulation of HSC biology. Moreover, in agreement with previous reports ([@bib43], [@bib31], [@bib28], [@bib54]), our results also suggest the involvement of these two proteins in megakaryocytic and lymphoid maturation. In future studies, we shall analyze this issue in greater depth.

The in vivo silencing of PTPN13 or β-catenin reduced the total number of engrafted GFP^+^ cells in BM. However, it led to an increased frequency of both GFP^+^ LT-HSCs and GFP^+^ ST-HSCs. HSCs have a low proliferation rate ([@bib35]), and hence the enrichment in HSCs would explain the reduced number of engrafted GFP^+^ cells upon PTPN13 or β-catenin downregulation. This was confirmed by analysis of the Ki67 proliferation marker, which was significantly reduced in all progenitor subpopulations when compared to control cells. This is in agreement with the increase in quiescence detected in the GFP^+^ LT-HSCs and GFP^+^ ST-HSCs.

Nevertheless, these observations did not explain why the frequency of HSCs and their quiescence was increased upon downregulation of PTPN13 or β-catenin. Considering the involvement of β-catenin in the cell adhesion process ([@bib52]), we thought it worthwhile to study whether attachment to the BM was altered. Surprisingly, our in vivo data showed a higher adhesion of mouse progenitor cells to the BM niche upon PTPN13 or β-catenin downregulation. These results are in agreement with many in vitro data that we report showing the alteration of cell adhesion when PTPN13 or β-catenin levels are modified, both in HEL cells and in also in murine hematopoietic progenitor cells. We therefore wondered whether the expression of genes coding for CAMs was altered. The expression of ten different genes, most of them expressed in HSCs ([@bib36]), was monitored in a cell line downregulated for PTPN13 or β-catenin. Interestingly five of these genes (*ITGA4*, *CDH1*, *CDH12*, *NCAM2*, and *RELN*) were upregulated; no differences were found in one of them (*ITGA5*), and only three of them were downregulated (*ITGA11*, *ITGAL*, *CDH5*). These dramatic changes at the cell surface could ultimately account for the increased adhesiveness. It has been reported previously that β-catenin suppresses the expression of cadherin genes ([@bib12]). Our analysis of *CDH1* gene promoter activity allows us to propose that some of the CAMs coding genes may be β-catenin transcriptional targets, while PTPN13, preserving β-catenin stability ([@bib43]), would contribute to the transcriptional regulation of these genes. The biology of stem cells depends on their relationship with the niche, and it is clear that CAMs would play a leading role in this respect. For example, it is well known that *CDH1* is required for the survival and self-renewal of hESCs ([@bib18]), and to maintain HSC multipotency in *Drosophil*a ([@bib11]). Recent reports show that *CDH1* overexpression enhances the generation of induced pluripotent stem cells (iPS) ([@bib4]), or the conversion from primed to naive-like pluripotent stem cells (PSCs) ([@bib29]). Moreover, it has recently been shown that a low expression of *Itgal* is linked to HSC long-term reconstitution capacity ([@bib8]).

We believe that the alteration of cell adhesion capacity may have important functional consequences, explaining the differences that we observed in the cell cycling and quiescence of hematopoietic progenitors. Supporting this notion, here we show that the downregulation of PTPN13 or β-catenin significantly reduces cell cycling and increases the quiescence of Lin^--^ progenitor cells co-cultured with mMSCs. It is worth noting that this effect is attained by direct cell-cell contact, since no effects were seen during transwell co-culture experiments. In short, we propose that the greater adhesiveness would be responsible for the reduced proliferation and increased quiescence upon PTPN13 and β-catenin downregulation observed in the in vivo experiments, in agreement with previous studies showing that quiescent cells are tightly bound to the BM niche ([@bib47]). Osteoblast seem to play a key role in the maintenance of HSC quiescence ([@bib2]), which may be related to a physical contact between osteoblast and HSCs ([@bib56]). Here, we show that the interaction with mesenchymal stroma cells might be also important for the regulation of HSC quiescence. Accordingly, we speculate that different types of niche cells might cooperate to maintain such quiescence.

We surmise that β-catenin and PTPN13 must be important for integrating the different signals received from the niche. Our results support this notion, since treatment with mesenchymal cell-conditioned medium led to the downregulation of PTPN13 and β-catenin, together with an increase in cell adhesiveness that could be explained by the change in CAM expression. The relevance of β-catenin in the context of cellular signaling has also been suggested for other types of stem cells ([@bib30], [@bib19]). The fact that PTPN13 and β-catenin levels were modified by several cytokines (Wnt3a, TPO, CXCL12, and SCF) suggests to us that these two proteins could be targets of multiple signaling pathways emanating from the niche. CXCL12 and Wnt can synergize for the stabilization of β-catenin in cancer cells ([@bib25]). SCF reinforces TPO signaling in megakaryocyte progenitors ([@bib6]). Regarding our results, it is feasible that different signaling pathways would converge at the level of PTPN13 and β-catenin, and hence these proteins would contribute to the integration of these signals by HSPCs.

The use of HSCs in regenerative medicine is of paramount importance ([@bib9]). Bearing in mind our results, we suggest that PTPN13 and β-catenin might be interesting therapeutic targets, since the modification of their levels could facilitate the mobilization of HSCs from donors or favor engraftment in recipients.

In conclusion, we show that the modulation of PTPN13 and β-catenin levels must play an essential role in the regulation of HSC adhesiveness, quiescence, and proliferation. Our data are consistent with the notion that the levels of PTPN13 and β-catenin must be kept low in order to preserve HSC quiescence and attachment to the niche. We also show that the levels of these two proteins are modified by different signals that are important for HSC development, such as Wnt, TPO, CXCL-12, and SCF. We propose that the modulation of PTPN13 and β-catenin levels in HSC would be of paramount importance for the integration of such signals ([Figure 7](#fig7){ref-type="fig"}D).

Experimental Procedures {#sec4}
=======================

Cell Lines {#sec4.1}
----------

HEL cells were grown in RPMI medium supplemented with 10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, and 2 mM L-glutamine. HEK293T cells and immortalized human bone marrow stroma cells (hMSC-TERTs) were grown in DMEM medium supplemented with 10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, and 2 mM L-glutamine ([@bib23]). Mesenchymal cell conditioned medium (MC-CM) was harvested after 72 hr, centrifuged, and filtered.

qRT-PCR {#sec4.2}
-------

RNA was extracted with TRI reagent (Sigma) or with an RNAspin mini kit (GE Healthcare Life Sciences). The RevertAid M-MuLV retrotransciptase (Fermentas) or the GeneChip WT Terminal Labeling Kit (Affymetrix) was used to generate cDNA. qPCR was carried out using the Go-Taq qPCR master mix (Promega) in a StepOne Real-Time PCR System (Applied Biosystems). Analysis of PCR data was performed by the comparative C~T~ method (ΔΔCT) ([@bib45]), using actin as an endogenous control. Oligonucleotide sequences are provided as [Supplemental Information](#app2){ref-type="sec"}.

Animals {#sec4.3}
-------

C57BL/6 mice were obtained from Charles River Laboratories and from the University of Salamanca Animal Facility Unit. All mice were kept at the pathogen-free animal facilities of University of Salamanca and were monitored daily. All experiments carried out on animals were approved by the Bioethics Committee of the University of Salamanca.

Lentiviral Production for RNA Interference {#sec4.4}
------------------------------------------

The expression of PTPN13 and β-catenin was reduced by lentiviral infection with specific small hairpin RNAs (shRNA). An oligonucleotide against firefly luciferase was used as a control, as previously described ([@bib42], [@bib43], [@bib40]).

Bone Marrow Cell Purification and Lentiviral Transduction {#sec4.5}
---------------------------------------------------------

BM cells were flushed with RPMI medium from femurs and tibias. Preparations were filtered to remove debris and washed twice in phosphate-buffered saline. Lin^--^ cells were purified with the Lineage Cell Depletion Kit for mice (MiltenyiBiotec), according to the manufacturer's instructions. Lin^--^ cell lentiviral transduction was performed as described ([@bib43]).

Bone Marrow Transplantation {#sec4.6}
---------------------------

Syngenic C57BL/6 recipient mice received two doses of 5Gy, separated in time by 2 hr, from a Cs source (Gammacell 1000 Elite, Nucleus Facility, University of Salamanca), and were transplanted 6 hr after the second irradiation. 3 × 10^5^ of unsorted lentiviral transduced Lin^--^ cells were injected intravenously through a tail vein of recipients, 24 hr after spinoculation. shRNA-carrying cells were identified by GFP expression. In vivo hematopoiesis was followed over 8 weeks after transplantation. A schematic representation of the experimental setting can be seen in [Figure S1](#mmc1){ref-type="supplementary-material"}B.

Flow Cytometry {#sec4.7}
--------------

The lineage-specific markers used were as follows: CD41, CD61, and CD42d for megakaryocytes; Ter119 for erythrocytes; Gr1 and CD11b for granulocytes and macrophages; CD19 and B220 for B cells, and CD3 for T cells. B cell maturation was analyzed in BM: ProB (B220^+^CD43^+^IgM^--^), PreB (B220^+^CD43^--^IgM^--^), and ImmBcells (B220^+^CD43^--^IgM^+^). T cell maturation was analyzed in the thymus: DN1 (CD44^+^CD25^--^), DN2 (CD44^+^CD25^+^), DN3 (CD44^--^CD25^+^), and DN4 (CD44^--^CD25^--^). DN (CD4^--^CD8^--^), DP (CD4^+^CD8^+^), CD4^+^ SP (CD4^+^CD8^--^), CD8^+^ SP (CD4^--^CD8^+^); BM Lin^--^ cell subpopulations were identified as follows: LSKs (Lin^--^c-KIT^+^SCA1^+^), LT-HSCs (Lin^--^c-KIT^+^SCA1^+^CD34^--^FLT3^--^), ST-HSCs (Lin^--^c-KIT^+^SCA1^+^CD34^+^FLT3^--^), LMPPs (Lin^--^c-KIT^+^SCA1^+^CD34^+^FLT3^+^), CMPs (Lin^--^c-KIT^+^SCA1^--^CD34^+^CD16/32^--^), CLPs (Lin^--^c-KIT^lo^, SCA1^lo^IL-7-Rα^--^), MEPs (Lin^--^c-KIT^+^SCA1^--^CD34^--^IL-7-Rα^--^CD16/32^--^), GMPs (Lin^--^c-KIT^+^SCA1^--^CD34^+^ IL-7-Rα^--^CD16/32^+^). Fluorescence minus one (FMO) controls were used for fluorescence-activated cell sorting (FACS) gating optimization ([@bib21]). The number of quiescent LT-HSCs was analyzed by staining of the Lin^--^ fraction with specific surface markers, together with 1 μg/ml pyronin Y (PY), 10 μg/ml 7ADD and 10 μg/ml ADD, as previously described ([@bib44]). Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) incorporation was performed with the APC BrdU Kit (BD Biosciences), following the manufacturer's instructions. The results were analyzed with the FACS Flowing 2 and Infinicyt Programs.

Isolation of Bone-Associated Cells {#sec4.8}
----------------------------------

BM cells were fully flushed from the femurs and tibias of transplanted animals. The bones were then digested with 0.02 mg/ml collagenase/dispase (Roche) for 2 hr at 37°C with constant agitation. Flushed BM cells and collagenase-/dispase-digested bones were analyzed by flow cytometry to determine the percentage of LSK cells (CD45^+^Lin^--^c-KIT^+^SCA1^+^) in each fraction.

In Vitro Adhesion Assays {#sec4.9}
------------------------

Cell adhesiveness was monitored in 100 μg/ml collagen- or 20 μg/ml fibronectin-coated plates. Cells were seeded for 3 hr at 37°C and washed twice with PBS, and the proportion of adhered cells was measured with the MTT assay ([@bib40]) in the case of HEL cells, or by evaluating the % of GFP^+^ cells by flow cytometry in the case of BM primary cells.

*CDH1* Promoter Luciferase Reporter Assay {#sec4.10}
-----------------------------------------

*CDH1* promoter activity was analyzed in 293T with the reporter plasmid pGL-E-Cad (−427+53) ([@bib16]) in the absence or presence of a plasmid overexpressing a β-catenin stable mutant (pWPI-β-cateninS33Y). Luciferase activity was normalized with respect to β-galactosidase transfection control as described ([@bib43]).

Isolation of Mouse Mesenchymal Stromal Cell {#sec4.11}
-------------------------------------------

BM was harvested from femurs of 8- to 10-week old C57BL/6 mice by flushing with RPMI medium. The cells were resuspended after washing in complete MesenCult medium (STEMCELL Technologies) and cultured at 37°C and 5% CO~2~. Non-adherent cells were removed after 72--96 hr in culture; adherent cells were harvested by trypsinization (0.05% trypsin-EDTA, GIBCO Invitrogen) when 90% confluence had been reached, after which they were replated. The medium was changed every 3--4 days. For co-culture assays, mMSC were used at passage 3--5.

Immunohistochemical Analysis {#sec4.12}
----------------------------

Immunohistochemical analysis on femurs sections was performed as described before ([@bib5]). shRNAs modified cells were identified by GFP expression with a rabbit monoclonal anti-GFP antibody (AbCam). Primary antibody was revealed using a biotinylated secondary antibody and the ABC kit (Vector Laboratories) with Diaminobenzime (DAB, Sigma-Aldrich). Finally, slides were mounted and observed with an Olympus BX41TF microscope (Olympus Optical).

Statistical Analyses {#sec4.13}
--------------------

Statistical analyses were performed using Student's t test. Differences were considered statistically significant when p \< 0.05.
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![Silencing of PTPN13 or β-Catenin in Mouse Hematopoietic Progenitor Cells Decreases the Number GFP^+^ in the Bone Marrow\
(A) PTPN13 and β-catenin localization in Lin^--^ cells was analyzed by immunostaining with specific antibodies. Nuclei were identified by DAPI staining. A representative of three different experiments is shown.\
(B) Lin^--^ cells were modified with shRNA specific against PTPN13 or β-catenin, an shRNA against luciferase was used as a control. shRNA-carrying cells were identified by GFP expression (n = 4 independent experiments).\
(C) No differences were found in the frequency of GFP^+^ Lin^--^ or GFP^+^ LSK cells during in vitro culture (n = 4 independent experiments).\
(D and E) Lethally irradiated mice were transplanted with Lin^--^ modified cells. Spleen GFP^+^ cells were sorted and PTPN13 or β-catenin mRNA levels were analyzed in the corresponding downregulated cells by qRT-PCR (n = 4 different mice) (D) and immunoblotting (E) (n = 3 different mice).\
(F) The frequency of GFP^+^ cells in different compartments in the mice was analyzed 8 weeks after transplantation (n = 5--8 different mice). Representative flow cytometry diagrams are shown. Numbers next to boxed areas indicate the percentage of cells in each region.\
Means ± SD are shown. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![PTPN13 or β-Catenin Silencing Increases the Number of Hematopoietic Stem Cells\
In vivo analysis of hematopoiesis in mice transplanted with Lin^--^ control cells (Luc RNAi) or Lin^--^ cells knocked down for PTPN13 or β-catenin.\
(A) Identification of LSKs in BM (n = 9--10 different mice).\
(B) LT-HSCs, ST-HSCs, LMPPs in BM (n = 8--10 different mice).\
(C) Analysis of committed progenitors in BM: CLPs, CMPs, GMPs, and MEP (n = 9--12 different mice).\
(D) Analysis of megakaryocytic markers (CD41, CD61, and CD42d) in BM (n = 4--8 different mice).\
(E) Analysis of T cell (CD3^+^) in thymus and PB (n = 6--11 different mice).\
(F) Thymocytes at late stages of maturation were analyzed by staining with CD4- and CD8-specific antibodies: DP (CD4^+^CD8^+^), CD4^+^ SP (CD4^+^CD8^--^), CD8^+^ SP (CD4^--^CD8^+^) (n = 7--9 different mice). Representative flow cytometry diagrams are shown. Numbers next to boxed areas indicate the percentage of cells in each region.\
See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![PTPN13 or β-Catenin Silencing Reduces HSC Cycling and Increases Quiescence\
In vivo analysis of BM progenitors in mice transplanted with Lin^--^ control cells (Luc RNAi) or Lin^--^ cells knocked down for PTPN13 or β-catenin.\
(A) Lin^--^ cells were stained with 7AAD and the frequency of cells in G~0~/G~1~ was analyzed by flow cytometry (n = 4--6 different mice). A representative diagram is shown.\
(B) The percentage of Ki67^+^ proliferating cells was analyzed in different subpopulations of progenitor cells (n = 6--8 different mice).\
(C) LT-HSCs and ST-HSCs quiescence was analyzed by PY/7AAD staining. The downregulation of PTPN13 or β-catenin increases the proportion of quiescent cells. A representative experiment is shown.\
Means ± SD are shown.](gr3){#fig3}

![PTPN13 or β-Catenin Silencing Increases Cell Adhesiveness and the Upregulation of Cell Membrane Adhesion Molecules\
(A) The proportion of Lin^--^(CD45^+^Lin^--^) and LSKs (CD45^+^Lin^--^c-KIT^+^SCA1^+^) cells was analyzed in collagenase-/dispase-digested bones after BM had been flushed out (n = 4--5 different mice). The frequency of Lin^--^ and LSKs strongly attached to the bone was higher in mice in which PTPN13 or β-catenin had been silenced.\
(B and C) PTPN13 or β-catenin was silenced in HEL cells. The levels of expression were analyzed by qRT-PCR (n = 5 or 8 independent experiments) (B) and immunoblotting (n = 3 independent experiments) (C).\
(D) Cell adhesiveness to collagen- or fibronectin-coated plates was analyzed in these cells (n = 5--7 independent experiments).\
(E) The expression of several genes coding for CAMs was analyzed by qRT-PCR (n = 4--9 independent experiments).\
(F) *CDH1* promoter activity was analyzed by luciferase reporter assay in the presence or absence of a β-catenin stable mutant (β-catenin S33Y) (n = 4 independent experiments).\
Means ± SD are shown. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![PTPN13 and β-Catenin Are Targets of Several Signaling Pathways\
(A and B) HEL cells were treated with mesenchymal cell-conditioned medium (MC-CM). The levels of PTPN13 and β-catenin protein and messenger (A) and the levels of several genes coding for CAMs were analyzed (B) (n = 4 independent experiments). HEL cells were treated with 100 ng/ml Wnt3a, 100 ng/ml TPO, 100 ng/ml CXCL-12 or 100 ng/ml SCF, and the following parameters were analyzed.\
(C) PTPN13 and β-catenin messenger levels (n = 4--5 independent experiments).\
(D) PTPN13 and β-catenin proteins levels (n = 3--5 independent experiments).\
(E) Expression of several genes coding for CAMs (n = 4--6 independent experiments). Messenger levels were analyzed after 8-hr treatment, and protein levels were monitored at different time points.\
In (B) and (E), upregulated genes are shown in blue, and downregulated genes are in yellow. Means ± SD are shown. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![Increased Adhesion of Mouse BM Progenitor Cells by PTPN13 or β-Catenin Silencing or by Treatment with Mesenchymal Cell-Conditioned Medium\
(A) Lin^--^ progenitor cells were purified after flushing the BM of the transplanted animals (n = 4--5 different mice).\
(B) The hematopoietic cells that remained attached to the bone were obtained after collagenase/dispase digestion (n = 4--9 different mice). Both sources of cells were seeded in collagen- or fibronectin-coated plates, or in a monolayer of mouse mesenchymal stroma cells (mMSCs). 4 hr later, non-adherent cells were removed by gentle washing with PBS. The relative adhesion was monitored by comparing the percentage of GFP^+^ adhered cells to the initial % GFP^+^ cells.\
(C) Adhesion to collagen- or fibronectin-coated plates of Lin^--^ cells treated with mesenchymal cell-conditioned medium (MC-CM) or with control medium during 4 hr (n = 3 independent experiments).\
(D) Messenger levels for PTPN13 and β-catenin in Lin^--^ cells treated with MC-CM or control medium during 8 hr.\
(E) Messenger levels for several genes coding for CAMs treated with MC-CM or control medium during 8 hr (n = 5 independent experiments). Upregulated genes are shown in blue, and downregulated genes are in yellow. Means ± SD are shown.](gr6){#fig6}

![PTPN13 or β-Catenin Silencing Reduces HSC Cycling and Increases Quiescence\
Lin^--^ cells were transduced in vitro with lentiviruses carrying shRNAs against PTPN13, β-catenin, or luciferase as a control, as depicted in [Figure S1](#mmc1){ref-type="supplementary-material"}B. Cells were cultured in control medium or upon co-culture with mMSCs with or without a transwell device during 48 hr. The following parameters were analyzed in the three different culture conditions.\
(A) Percentage of Ki67^+^ proliferating cells (n = 4 independent experiments).\
(B) Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) incorporation to replicating cells after 16 hr of BrdU treatment (n = 5 independent experiments).\
(C) Cell quiescence estimated by PY/7AAD staining (n = 4 independent experiments).\
(D) Proposed model for PTPN13 and β-catenin as regulators of intracellular signaling in HSPCs. PTPN13 and β-catenin can be regulated by cytokine signaling. Low levels of these proteins would increase HSPCs attachment to the niche through the upregulation of CAMs. A stronger attachment to the niche would reduce cell cycling and increase the quiescence of HSPCs.\
Means ± SD are shown.](gr7){#fig7}
